Unlike substitution therapies for opioid use disorders, the effectiveness of prescribed psychostimulants for stimulant use disorders is uncertain. Well-designed clinical trials will yield insights into benefits and risks, guiding treatment decisions and ensuring patient safety in managing stimulant use disorders.